WHO ICTRP trial

Research study on whether a combination of 2 medicines (NNC0194-0499 and…

CTIS2023-506961-74-00 · EU Clinical Trials Information System · Not Recruiting

Key facts

Trial ID CTIS2023-506961-74-00
Public title Research study on whether a combination of 2 medicines (NNC0194-0499 and Semaglutide) works in people with non-alcoholic steatohepatitis (NASH)
Scientific title Efficacy and safety investigation of NNC0194-0499 co-administered with semaglutide in subjects with non-alcoholic steatohepatitis: a dose-ranging, placebo-controlled trial. - NN9500-4656
Primary sponsor Novo Nordisk A/S
Registry EU Clinical Trials Information System
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): Yes Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No
Countries United Kingdom;India;Korea, Democratic People's Republic of;Canada;Taiwan;Turkey;Australia;Japan;Russian Federation;United…
Conditions Non-alcoholic steatohepatitis (NASH);Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Interventions Product Name: , Product Code:PRD7856005, Pharmaceutical Form: SOLUTION FOR INJECTION, Other descriptive name: , Strength: , Product Name: Placebo C, Product Code:N/A, Pharmaceutical Form: N/A, Other descriptive name: N/A , Strength…
Registration date Apr 19, 2024
Target size 698
Secondary IDs U1111-1255-5551;2020-003566-39
Registry page euclinicaltrials.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations